Industry Briefs: Mar. 19, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Company News
Bend Reasearch has launched a biotherapeutics-development initiative.
OctoPlus has formed an agreement with a top-five generic-drugs company for the development of a formulation for an injectable drug.
QRxPharma has signed a license and option agreement with Actavis.
Recipharm has been contracted by ViroPharma to complete a full commercial scale-up manufacture of DuoCort’s Plenadren (hydrocortisone modified-release tablet).
Shire plans to acquire FerroKin BioSciences for an upfront payment of $100 million.
ThromboGenics has formed a commercialization agreement for Ocriplasmin with Alcon.
People News
Stuart E. Needleman has been named president and chief operating officer of Aptuit, effective immediately.
Avanir Pharmaceuticals has appointed Rohan Palekar as chief commercial officer.
Unigene has appointed David Moskowitz as chief financial officer.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.